chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swelling; body ache; Pain; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling), MYALGIA (body ache), ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (Pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced ARTHRALGIA (joint pain). On 24-Feb-2021, the patient experienced VACCINATION SITE SWELLING (swelling), MYALGIA (body ache) and VACCINATION SITE PAIN (Pain). At the time of the report, VACCINATION SITE SWELLING (swelling), MYALGIA (body ache), ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (Pain) outcome was unknown.            No concomitant medications were reported.   No corrective treatment was provided.
On May 17th 2021, I woke up with numbness on the left side of my face.  The symptoms were all sensory and not motor, there was no drooping or muscle weakness.  I felt pain and tingling and electric shock type of symptoms along with numbness involving the three branches of the Trigeminal nerve.  Initially I felt numbness mostly in the V3 branch involving my lower jaw and it gradually moved up to involve my teeth and gums and under my eye.  Pain in my gums caused me not to be able to eat and the headaches that this was causing were getting worse.  I went in to urgent care on May 26th to have diagnostic tests done including a CT scan with and without contrast which ruled out stroke and aneurysm.  I then had an MRI without contrast to rule out multiple sclerosis which came back unremarkable.  Which then led to the diagnosis of trigeminal neuralgia.  Initially I was prescribed nortriptyline for my symptoms.  I tried taking this and I didn?t notice any improvement in my symptoms and the side effects made it difficult for me to complete my daily work tasks.  I was then prescribed carbamazepine and again, I experienced negative side effects with no reduction in my symptoms.  I have no other risk factors for developing trigeminal neuralgia, I am otherwise healthy with mild hypertension that is well controlled on medication and I have not had any injury or surgery near this nerve that would put me as risk.  At this point I have been asking my neurologist if I could have an MRI with contrast to see if there are vessels compressing the nerve.  I feel that I need to get to the bottom of this and keep trying to find the root cause of this because the medication does not improve my symptoms.  I am trying to figure out it this is an immune triggered attack on the nerve or if there is something compressing the nerve.  I have never had any nerve palsies before, and I don?t have any chronic illness such as diabetes that would increase my risk of developing nerve palsy.
4 days after injection, vomited bilious material and had abdominal / cramp.
Acute exacerbation of paranoid ideation, phobia and obsessive thoughts to a level leading to a constant panic state. Although he patient has had some occasional background fears that never necessitated intervention or affected his daily function, he has never experienced such intense and constant symptoms.
Pt recv vax on 3/18/99; on 3/19/99 pt exp swelling, warmth, soreness, edema, erythema and mild tenderness to palpation of lt arm
Vaccines given on 9/27/02. Returned to clinic 9/30/02 with sibling. Arm red, swollen right arm. DTaP in right arm.
approx 5 hrs p/vax began having joint pain of extremities, fever 101.8, severe h/a; no localized react @ inj site; sx lasted approx 24 hrs no other prob;
Within 30 minutes, left side of face started feeling numb, tingling.   Spread to right side of face.
The day following vaccination patient began experiencing tachycardia, palpitations, paresthesia in hands, feet, face. Symptoms are persisting.
Vaccine leaked and ran down patient's arm during administration. Minimal, if any, vaccine remained during injection. Patient was revaccinated with full dose same day. No adverse signs or symptoms reported.
Moderate full body muscular soreness in the morning (~16 hours out).  Moderate fatigue by afternoon (~20 hours out).  Symptoms fully subsided by following morning (~36 hours)
Covid symptoms, diarrhea, sore throat, tiredness, body aches, headaches, sinus pain.
Initial report received from a non-health care professional on 17 April 2014. A patient whose demographic details including initials, age, gender and date of birth not reported had received a dose of TYPHIM VI (Lot number, dose number, route and site of vaccination not reported) on an unspecified date. A patient had received ANTHRAX and Typhoid vaccine and experienced adverse event. It was also reported that three patients were vaccinated with ANTHRAX and Varicella and the fifth person was vaccinated with just ANTHRAX. The laboratory details and corrective treatment were unknown. At the time of this report the outcome of the adverse event was unknown. Documents held by sender: none.
rash is a little hard and warm; rash is a little hard and warm; "nice" red rash just below the injection site; headache; fever; dizziness; flu like symptoms; chill; tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), INFLUENZA LIKE ILLNESS (flu like symptoms), VACCINATION SITE WARMTH (rash is a little hard and warm), VACCINATION SITE INDURATION (rash is a little hard and warm) and CHILLS (chill) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Dizziness. Concomitant products included MONTELUKAST, METOPROLOL, HCTZ, LEVOTHYROXINE, LORATADINE (LORATADIN), ACETYLSALICYLIC ACID (ASPRIN), FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]), POTASSIUM, MECLIZINE HCL and VITAMINS NOS (MVI [VITAMINS NOS]) for an unknown indication.   On 14-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced DIZZINESS (dizziness), INFLUENZA LIKE ILLNESS (flu like symptoms), CHILLS (chill), FATIGUE (tired), HEADACHE (headache) and PYREXIA (fever). On an unknown date, the patient experienced VACCINATION SITE WARMTH (rash is a little hard and warm), VACCINATION SITE INDURATION (rash is a little hard and warm) and INJECTION SITE RASH ("nice" red rash just below the injection site). On 16-Mar-2021, DIZZINESS (dizziness), INFLUENZA LIKE ILLNESS (flu like symptoms), CHILLS (chill), FATIGUE (tired), HEADACHE (headache) and PYREXIA (fever) had resolved. At the time of the report, VACCINATION SITE WARMTH (rash is a little hard and warm), VACCINATION SITE INDURATION (rash is a little hard and warm) and INJECTION SITE RASH ("nice" red rash just below the injection site) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable.  No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
The day following the injection, I experienced chills, lack of appetite, fever (101.4), and fatigue. That evening I sweated profusely during sleep. Two days after the injection, I had continued fatigue, lack of appetite, and unusual sweating with little to no activity. Third day, continued fatigue but no unusual sweating. Appetite is returning slowly
Lightheadness & nausea around midnight.  Woke up around 3:00 am with fever, headache and body aches.  This continued all day on 3/13/21.  On 3/14/21 the fever and headache continued all but the body aches were better.  I took Tylenol every 6 hours starting around 9:00 am on 3/13/21.  Also, arm was very sore and warm to the touch 3/13/21-3/14/21 and continued to be sore until around 3/19/21.
Client states she started her menstrual cycle on Tuesday 8/3/2021 and received her vaccine on 8/6/2021.  She states she has not stopped menstruating since receiving her vaccine.  She states the discharge is a light amount and brown with clots.  She described it as "when her period is almost over, but it just never stopped"  She states she took her first pill of her new pack on 8/7/21.  States she has not been evaluated by a medical professional or her OBGYN.  Advised her that she should contact her medical professional or OBGYN.
Arm was warm to touch; Swelling; Pain in arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), FEELING HOT (Arm was warm to touch), SWELLING (Swelling) and CHILLS (Chills) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 000A21A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced CHILLS (Chills). On 28-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 14-Mar-2021, the patient experienced FEELING HOT (Arm was warm to touch) and SWELLING (Swelling). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 27-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, PAIN IN EXTREMITY (Pain in arm), FEELING HOT (Arm was warm to touch) and SWELLING (Swelling) outcome was unknown.            No concomitant medication information not provided.  Treatment also includes ice.
This spontaneous report was received from a physician assistant, via company representative, and refers to a 43 year old female patient. No information was provided regarding the patient's medical history or concurrent conditions. On 22-SEP-2017, the patient was vaccinated with PNEUMOVAX 23 in the left deltoid for prophylaxis (route of administration, lot number, and expiration date were not provided). On the same day, the patient was also vaccinated with an unspecified influenza virus vaccine (reported as: flu vaccine)in the right deltoid, and received medroxyprogesterone acetate(DEPO-PROVERA) in the right glute (formulation, dose, strength, indication, frequency, lot number and expiration date were not provided). After receiving the PNEUMOVAX 23, the patient's left arm was red, warm, and painful. The patient also had swollen glands after the administration of the vaccine. At the time of this report it was unknown if the patient had recovered from the events. Causality assessment between therapy with PNEUMOVAX 23 and the events was not provided.
mom reported pt to have a fever of 105 @ house; in clinic it was  registered @ 101 rectally
soreness in the left arm; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (soreness in the left arm) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     no medical history provided by the reporter.  Concomitant products included OMEPRAZOLE for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced MYALGIA (soreness in the left arm). At the time of the report, MYALGIA (soreness in the left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was reported for the events.    This case was linked to MOD-2021-086047 (Patient Link).
@ 230PM lump rt thigh no reddness or warmth; pt c/o pain & difficulty w/walking; @ 10PM temp 102.7; had gotten 2 days liquid Advil during daytime; tried to reach MD unable to contact;
No symptoms reported. No additional AE/PQC; Inbound call from a medical assistant with a physician on the back line reporting AE for VARIVAX.  TE case filed under 02458467. AE details were provided by medical assistant. No symptoms reported. No additional AE/PQC.  ?    Names of vaccines invo; This spontaneous report has been received form a medical assistant, regarding a patient of unknown age and gender. The patient's pertinent medical history, past drug reactions or allergies, concurrent conditions and concomitant therapies were not provided.  On 02-AUG-2023, the patient was vaccinated with an improperly storage first dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection, subcutaneously as prophylaxis (lot number: X006983, which was determined to be valid, with an expiration date on 07-MAR-2025) (strength, dose and anatomical location of administration were not reported) (Product storage error).  The administered dose underwent a temperature excursion of -12.48 degrees Celsius for 1 hour and 30 minutes. There was a no previous temperature excursion reported.   No additional adverse event was reported.
Patient is a 30 year old male who has completed a 30-minute observation period with the following signs and symptoms of an adverse reaction: loss of consiousness and other - syncopal episode, dizziness. Pt endorsed that he is nervous after getting the vaccine, then felt dizzy. while sitting down, he tried to distract himself by checking his cellphone then felt anxious and passed out. History of anxiety with procedures and riding the plane per patient. . Hx of having dizziness and felt like fainting on his 1sr COVID 19 vaccine. Per pt, he ate breakfast with oatmeal. Pt also endorsed he is athletic. Pt endorse that he drank 2 beers last night. Denies taking any blood thinners or Aspirin.    Staff found patient on the ground with some jerking of arms, LOC lasted for 15-30 seconds per RN. Pt placed on wheelchair and sent to evaluation area set up with gurney.   Physical exam shows abrasion on the right tempo/parietal area otherwise no step offs and no laceration. No spinall midline tenderness. Not intoxicated. No focal neuro deficit. Not taking any anticoagulants. Otherwise physical exam unremarkable, improved, and stable.   Gave Concussion educational teaching and monitoring for 24 hours and ED precautions. This is not an allergic reaction. This is more likely vasovagal syncope with fall, head injury and abrasion on right tempo/parietal area. To send home with transport. Stable to go home.    Called attending Dr., discussed case and plan for patient. Agreed with the plan.
Widespread joint pain and inflammation, bilaterally including fingers, hands, wrists, elbows, shoulders, hips, toes, ankles, and knees. Overwhelming fatigue.  Still ongoing.
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Sep-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 24-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that on 24-Sep-2021 patient received the Moderna vaccine which expired on 22-Sep-2021.  No concomitant medication was provided by the reporter. No treatment information was provided by the reporter.
This spontaneous report as received from a nurse referring to a 70 year old male patient. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On 26-SEP-2017, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 lot # N010105 with expiration date 15-NOV-2018, for prophylaxis (dose and route of administration were not reported). No adverse effects were reported. It was stated that the temperature was 32 to 30 Fahrenheit degrees for 15 minutes. The call was made because a data logger. No previous temperature excursion was reported. This is one of several reports from the same reporter.; Sender's Comments: US-009507513-1710USA005003:
I had a low temperature 96 degrees and body aches and flu like symptoms. I was not sure if it was a Lupus flare up or related to the vaccine because that is what everyone told me, the vaccine caused flu like symptoms. I also had headaches most days following the vaccination. I had injection site redness and pain, muscle pain and complete body started to have pain. Tele visit with DR April 6th 2021. May 18th I visited the DR as well. And May 25th 2021. Prior to that I did also visit the NP at that office as well, I don't have the date for that.
pt recv vax 14JUL95 & 9MAR98 pt devel 50 lesions over the entire body & itchiness;pt was afeb;
Fever 100.7 with Tylenol, nausea, vomiting, chills and cold sweat, moderate to severe body pain. Better as time pass but still not gone but shot was yesterday.
0.2ml of undiluted COVID Pfizer (5-11 years) was given. RN unaware of medication error until after patient had left. Pt was observed for 15 minutes with no reaction. Attending was notified and called and informed the mother, mother states no reaction.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) and EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2022 at 1:33 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 26-Mar-2022 at 1:33 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) and EXPIRED PRODUCT ADMINISTERED (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. No treatment medication information was given.
Swelling and soreness in arm. Rash, extreme itchiness, chills, sweating, coldness, tingling and swelling in neck, tingling and burning, stinging  in torso and arms,  confusion  still occurring 25 days later. Arythymia/tacardia may be normal due to temporarily stopping medication.
03/26/09 swelling began left arm. 03/27/09 reddness and hot feeling occured with fever of 101.8.  03/28 and 03/29 swelling increased with itching. Denies shortness of breath or nausea or vomiting. Applied alovera, symptoms are decreasing itching continues.
Pt vax /w Meruvax II experienced generalized weakness & paresthesis from feet to neck level. Also c/o of chest discomfort & shortness of breath on exertion. Generalized acute weakness w/ataxia of all limbs. Dx Guillian Barre Syd
Patient received the first Shingrix vaccine dose on 12-18-2020, then presented to pharmacy on 2-21-2021 with a dime-size, single, raised, red/brown, blister-like area on his left deltoid arm near the injection site. The edge was red/purple. He said it was not painful or itchy and if he accidentally bumped it on anything, it bled slightly. He said this appeared very shortly after receiving the vaccine and it has not gone away. He said he had no other symptoms or adverse effects and that this has never happened before with previous vaccines. Patient has not sought medical care as of today and was instructed to seek medical care ASAP from a physician or a dermatologist. Unsure whether this is due to the vaccine or not.
throbbing discomfort lt deltoid region extending up into clavicle area & lt neck w/warmth 8in same areas & into lt ear;unable to sleep d/t discomfort;
Information has been received regarding a case in litigation, from a lawyer, concerning a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. On 04-OCT-2011, the patient was vaccinated with ZOSTAVAX (strength, dose, anatomical route of vaccination, lot # and expiration date were not provided) for prophylaxis. On an unknown date, the patient was diagnosed with shingles and / or other zoster-related injuries after and, despite being inoculated with the ZOSTAVAX (shingles and vaccination failure). Due to the patient's shingles, on 21-AUG-2015, the patient was treated by a physician. Furthermore, it was reported that the patient suffered serious physical, emotional and economic damages as a result. The patient would continue to suffer ongoing injuries, included but not limited to: mental and physical pain and suffering (emotional distress and pain), extensive medical care and treatment for these injuries, significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of pre-existing conditions and activations of latent conditions, lost wages, loss of earning capacity and other losses and damages. At the time of report, the outcome of emotional distress and pain was reported as not recovered and the outcome of the patient regarding the vaccination failure, herpes zoster, quality of life decreased, and the pre-existing unspecified conditions aggravated was unknown. Additionally, the reporter considered herpes zoster, condition aggravated, quality of life decreased, pain, emotional distress and vaccination failure to be related to ZOSTAVAX. The reporter considered the events to be serious due to disabling, life-threatening, hospitalization and medically significant.
This spontaneous report was received from a physician via company representative refers to a 12 year old male patient. On an uknown date (reported as several weeks ago), the patient was vaccinated with a dose of 2 VARIVAX (Merck) (lot number, expiry date and route was not reported). On an unknown date (reported as within 24 hours post vaccination), the patient spiked a 103 degree fever. The outcome of the event was reported as recovered. Additional information is not expected.